Breast Cancer Core Needle Biopsy Market Size, Share Analysis and Forecast 2034

Breast Cancer Core Needle Biopsy Market Growth, Size, Trends Analysis - By Technology, By End-use- Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Q: How can I get a sample report on the Breast Cancer Core Needle Biopsy Market?

You can get the sample pages by clicking the link - Click Here

Published: Jul-2025	Report ID: HLCA25244	Pages: 1 - 248	Formats^*:
Category : Healthcare

Breast Cancer Core Needle Biopsy Market Introduction and Overview

According to SPER Market Research, the Global Breast Cancer Core Needle Biopsy Market is estimated to reach USD 1398.03 million by 2034 with a CAGR of 4.86%.

The report includes an in-depth analysis of the Breast Cancer Core Needle Biopsy Market, including market size and trends, product mix, Applications, and supplier analysis. The Breast Cancer Core Needle Biopsy Market was valued at USD 869.9 million in 2024 and is expected to grow at a CAGR of 4.86% from 2025 to 2034. The market is expanding rapidly, driven by the increased incidence of breast cancer and advances in imaging and biopsy technology. Core needle biopsies have several advantages over standard surgical procedures, including the fact that they are less intrusive, promote faster recovery, and are less expensive. As awareness of early detection grows worldwide, the demand for core needle biopsies is expected to rise further due to their critical role in early diagnosis and improved patient outcomes.

By Technology Insights

The ultrasound-based breast biopsy category has the biggest revenue share, owing to the increased desire for ultrasound-guided biopsies due to their numerous benefits. Product innovation and regulatory clearances are expected to accelerate segment growth. New product developments focused on increasing ultrasound visibility and ease of use in image-guided operations have boosted the segment. Furthermore, advances in ultrasound-based models for detecting metastases in breast cancer patients are projected to play a vital role in the segment's sustained expansion.

By End-use Insights

The hospital and diagnostic laboratories segment has the biggest revenue share. The rising number of patient visits to hospitals, together with the growing use of modern instruments and technology in healthcare facilities, is likely to offer a favourable environment for the segment's expansion. Furthermore, the segment is expected to develop at the quickest rate during the projected period, owing to the rapid increase in biopsy instrument installations. Technological improvements, such as the incorporation of artificial intelligence into diagnostic equipment, are likely to bolster the segment's growth potential.

Regional Insights

North America dominates the breast cancer core needle biopsy industry. Its strong market leadership is credited to modern healthcare systems, substantial research capabilities, and collaborative initiatives to raise patient awareness. Collectively, these characteristics increase early mammary tumour identification and management outcomes. Prominent medical institutions and diagnostic centres in the United States and Canada routinely promote frequent testing.

The breast cancer core needle biopsy industry in the United States is expected to increase steadily over the forecast period. The United States has a well-established healthcare system that provides access to cutting-edge medical technologies and highly trained healthcare workers. This allows for the use of modern diagnostic instruments, like core needle biopsies, which are minimally invasive and very effective in identifying breast tumours.

Get more information on this report: Download Free Sample PDF

Market Competitive Landscape

The Breast Cancer Core Needle Biopsy Market is dominated by established players such as Leading firms such as Hologic, BD, C.R. Bard, Leica Biosystems, and Cook Medical dominate the breast cancer core needle biopsy industry, owing to their ongoing innovation in minimally invasive technology. Their significant global presence, consistent product performance, and strategic partnerships with healthcare institutions all contribute to their competitive edge and market leadership.

Recent Developments:

In November 2024, Mammotome introduced Mammotome AutoCore, a core biopsy equipment for breast tissue inspections. The technology has substantial advantages over typical core needle devices, making procedures easier for healthcare providers and increasing the overall patient experience. By shortening the time required for biopsies, clinicians can execute treatments more effectively, which improves both clinical outcomes and patient comfort.
In November 2024, a team of researchers from the Centre for Global Women's Health Technologies received USD 10.4 million for breast cancer research. The study initiative aims to eliminate mortality and increase overall access to treatment and detection of breast cancer.

Scope of the report:

Report Metric	Details
Market size available for years	2021-2034
Base year considered	2024
Forecast period	2025-2034
Segments covered	By Technology, By End-use
Regions covered	North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered	Argon Medical Devices, Becton - Dickinson and Company, C.R. Bard, Inc., Cook Medical Incorporated, Encapsule Medical Devices LLC, Ethicon Surgical Technologies, Gallini SRL, Hologic, Inc., Intact Medical Corporation, Leica Biosystems Nussloch GmbH.

Key Topics Covered in the Report

Global Breast Cancer Core Needle Biopsy Market Size (FYâ€™2021-FYâ€™2034)
Overview of Breast Cancer Core Needle Biopsy Market
Segmentation of Global Breast Cancer Core Needle Biopsy Market by Technology Method (MRI-based Breast Biopsy, Ultrasound-based Breast Biopsy, Mammography-based Breast Biopsy, CT-based Breast Biopsy, Other Image Based Breast Biopsy)
Segmentation of Global Breast Cancer Core Needle Biopsy Market by End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes)
Statistical Snap of Global Breast Cancer Core Needle Biopsy Market
Expansion Analysis of Global Breast Cancer Core Needle Biopsy Market
Problems and Obstacles in Global Breast Cancer Core Needle Biopsy Market
Competitive Landscape in the Global Breast Cancer Core Needle Biopsy Market
Details on Current Investment in Global Breast Cancer Core Needle Biopsy Market
Competitive Analysis of Global Breast Cancer Core Needle Biopsy Market
Prominent Players in the Global Breast Cancer Core Needle Biopsy Market
SWOT Analysis of Global Breast Cancer Core Needle Biopsy Market
Global Breast Cancer Core Needle Biopsy Market Future Outlook and Projections (FYâ€™2025-FYâ€™2034)
Recommendations from Analyst

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source

2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs

2.2. Market size estimation

2.2.1. Top-down and Bottom-up approach

2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis

5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats

5.2. PESTEL Analysis

5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape

5.3. PORTERs Five Forces

5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry

5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Breast Cancer Core Needle Biopsy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Breast Cancer Core Needle Biopsy Market

7. Global Breast Cancer Core Needle Biopsy Market, By Technology (USD Million) 2021-2034

7.1. MRI-based Breast Biopsy
7.2. Ultrasound-based Breast Biopsy
7.3. Mammography-based (Stereotactic) Breast Biopsy
7.4. CT-based Breast Biopsy
7.5. Other Image Based Breast Biopsy

8. Global Breast Cancer Core Needle Biopsy Market, By End-Use (USD Million) 2021-2034

8.1. Hospitals & Diagnostic Laboratories
8.2. Pharmaceutical & Biotechnology Companies
8.3. Academic & Research Institutes

9. Global Breast Cancer Core Needle Biopsy Market, (USD Million) 2021-2034

9.1. Global Breast Cancer Core Needle Biopsy Market Size and Market Share

10. Global Breast Cancer Core Needle Biopsy Market, By Region, (USD Million) 2021-2034

10.1. Asia-Pacific

10.1.1. Australia
10.1.2. China
10.1.3. India
10.1.4. Japan
10.1.5. South Korea
10.1.6. Rest of Asia-Pacific

10.2. Europe

10.2.1. France
10.2.2. Germany
10.2.3. Italy
10.2.4. Spain
10.2.5. United Kingdom
10.2.6. Rest of Europe

10.3. Middle East and Africa

10.3.1. Kingdom of Saudi Arabia
10.3.2. United Arab Emirates
10.3.3. Qatar
10.3.4. South Africa
10.3.5. Egypt
10.3.6. Morocco
10.3.7. Nigeria
10.3.8. Rest of Middle-East and Africa

10.4. North America

10.4.1. Canada
10.4.2. Mexico
10.4.3. United States

10.5. Latin America

10.5.1. Argentina
10.5.2. Brazil
10.5.3. Rest of Latin America

11. Company Profile

11.1. Argon Medical Devices

11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments

11.2. Becton- Dickinson and Company

11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments

11.3. C.R. Bard, Inc.

11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments

11.4. Cook Medical Incorporated

11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments

11.5. Encapsule Medical Devices LLC

11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments

11.6. Ethicon Surgical Technologies

11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments

11.7. Gallini SRL

11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments

11.8. Hologic, Inc.

11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments

11.9. Intact Medical Corporation

11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments

11.10. Leica Biosystems Nuss Loch GmbH

11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments

11.11. Others

12. Conclusion

13. List of Abbreviations

14. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Frequently Asked Questions About This Report

How big is the Breast Cancer Core Needle Biopsy Market?

Breast Cancer Core Needle Biopsy Market is projected to reach USD 1398.03 million by 2034, growing at a CAGR of 4.86% during the forecast period.

What is the growth rate of the Breast Cancer Core Needle Biopsy Market?

Breast Cancer Core Needle Biopsy Market grew in Market size from 2025. The Market is expected to reach USD 1398.03 million by 2034, at a CAGR of 4.86% during the forecast period.

What is the anticipated CAGR of the Breast Cancer Core Needle Biopsy Market?

Breast Cancer Core Needle Biopsy Market CAGR of 4.86% during the forecast period.

How can I get a sample report on the Breast Cancer Core Needle Biopsy Market?

You can get the sample pages by clicking the link - Click Here

What is the Market size of the Breast Cancer Core Needle Biopsy Market?

Breast Cancer Core Needle Biopsy Market size is USD 1398.03 million from 2025 to 2034.

Which segment is expected to Breast Cancer Core Needle Biopsy Market?

Breast Cancer Core Needle Biopsy Market is covered By Technology, By End-use

Which region is expected to have the highest Market share in the Breast Cancer Core Needle Biopsy Market?

North America is anticipated to have the highest Market share in the Breast Cancer Core Needle Biopsy Market.

Who are the key players in Breast Cancer Core Needle Biopsy Market?

Argon Medical Devices, Becton - Dickinson and Company, C.R. Bard, Inc., Cook Medical Incorporated, Encapsule Medical Devices LLC, Ethicon Surgical Technologies, Gallini SRL, Hologic, Inc., Intact Medical Corporation, Leica Biosystems Nussloch GmbH.

What is the conclusion of the Breast Cancer Core Needle Biopsy Market?

The report includes an in-depth analysis of the Global Breast Cancer Core Needle Biopsy Market, including market size and trends, product mix, Applications, and supplier analysis